-
Watson seeks to market generic Jalyn
PARSIPPANY, N.J. — Watson Pharmaceuticals is hoping to be the first to market a generic version of a GlaxoSmithKline drug for men with an enlarged prostate, Watson said.
Watson announced that it filed a regulatory approval application to market a generic version of GSK’s Jalyn (dutasteride and tamsulosin hydrochloride) capsules, a treatment for symptomatic benign prostatic hyperplasia in men with enlarged prostates.
-
ReportersNotebook — Beauty Care, 8/1/11
SUPPLIER NEWS — Unilever has announced changes to its category and go-to-market structure to further support its growth plans and allow for a more efficient rollout of increasingly bigger and more scalable innovations. The changes include several executive moves, including the appointment of Dave Lewis, president of the Americas, as president of personal care, consisting of skin, deodorants, oral and hair.